Egg Biotech announced that the company reviewed and approved the repurchase plan on July 3, 2026. It plans to repurchase shares at no less than 50 million yuan and no more than 100 million yuan. The repurchase price will not exceed 12.51 yuan/share for employee stock ownership plans or equity incentives. In July 2026, the company repurchased a total of 715,700 shares, accounting for 0.14% of the total share capital. The transaction price range was 7.95 yuan/share to 8.1 yuan/share, and the total amount of capital paid was 5.7544 million yuan.

Egg Biotech announced that the company reviewed and approved the repurchase plan on July 3, 2026. It plans to repurchase shares at no less than 50 million yuan and no more than 100 million yuan. The repurchase price will not exceed 12.51 yuan/share for employee stock ownership plans or equity incentives. In July 2026, the company repurchased a total of 715,700 shares, accounting for 0.14% of the total share capital. The transaction price range was 7.95 yuan/share to 8.1 yuan/share, and the total amount of capital paid was 5.7544 million yuan.